ID   NCC-ES1-C1
AC   CVCL_UK81
SY   NCCES1C1
DR   DepMap; ACH-002780
DR   Wikidata; Q95992526
RX   PubMed=30324244;
WW   https://en.cellline.jp/product/ncc-es1-c1/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.).
CC   Doubling time: 33 hours (PubMed=30324244).
CC   Sequence variation: Gene fusion; HGNC; 3508; EWSR1 + HGNC; 3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=EWSR1 exon 7 fused to FLI1 exon 8 (PubMed=30324244).
CC   Derived from site: In situ; Bone, left tibia; UBERON=UBERON_0000979.
ST   Source(s): PubMed=30324244
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 12,13
ST   D21S11: 28,31
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 10,11
ST   vWA: 17,18
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 13
//
RX   PubMed=30324244; DOI=10.1007/s11626-018-0302-2;
RA   Oyama R., Kito F., Qiao Z.-W., Sakumoto M., Noguchi R., Takahashi M.,
RA   Toki S., Tanzawa Y., Yoshida A., Kawai A., Kondo T.;
RT   "Establishment of a novel patient-derived Ewing's sarcoma cell line,
RT   NCC-ES1-C1.";
RL   In Vitro Cell. Dev. Biol. Anim. 54:770-778(2018).
//